Science & Enterprise subscription

Follow us on Twitter

  • University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promisi… https://t.co/teoJmmS7Hi
    about 5 hours ago
  • New post on Science and Enterprise: Health Research Commercialization Company Launched https://t.co/IOKEXZQSg2 #Science #Business
    about 5 hours ago
  • A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its s… https://t.co/pluS8d03pW
    about 10 hours ago
  • New post on Science and Enterprise: Antibody Drug Biotech Raises $105M in Venture Funds https://t.co/9YmpThcKVv #Science #Business
    about 10 hours ago
  • https://t.co/PNy7n5Obv1
    about 14 hours ago

Please share Science & Enterprise

Merck Inks Three Covid-19 Vaccine, Therapy Deals

SARS-Cov-2 virus

Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections. . . . → Read More: Merck Inks Three Covid-19 Vaccine, Therapy Deals

Synthetic Bio Cancer Immunotherapy Company Acquired

Natural killer cell

A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma. . . . → Read More: Synthetic Bio Cancer Immunotherapy Company Acquired

Synthetic Bio Company Acquired in $2.35B Deal

E. coli bacteria

A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion. . . . → Read More: Synthetic Bio Company Acquired in $2.35B Deal

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Laptops on a table

Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Genentech, Biotech Partner on Multiple Sclerosis

Neurons illustration

A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis

Infographic – Top Tech Acquisition Timeline

Top tech industry acquisitions

The world’s five leading technology enterprises are acquiring more companies and with more money in recent years than before. . . . → Read More: Infographic – Top Tech Acquisition Timeline

Educational Robotics Spin-Off Company Acquired

Root tablet and robot

Root Robotics, a developer of robots that teach coding to school children, is now part of the consumer and educational robotics company iRobot Corp. . . . → Read More: Educational Robotics Spin-Off Company Acquired

Venture Funds, Mergers in A.I. Up Sharply in 2018

Glasses, computer screens

Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows. . . . → Read More: Venture Funds, Mergers in A.I. Up Sharply in 2018

Biogen Acquires Gene Therapy Company in $800M Deal

Eye exam

A company developing treatments for inherited eye diseases that replace malfunctioning with healthy genes is being acquired by biotechnology company Biogen. . . . → Read More: Biogen Acquires Gene Therapy Company in $800M Deal

Gene Therapy Company Acquired in $4.3B Deal

Retinal gene therapy

Spark Therapeutics, a biotechnology company that pioneered gene therapies, is being acquired by drug maker Roche Group in a deal valued at $4.3 billion. . . . → Read More: Gene Therapy Company Acquired in $4.3B Deal